The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

A new cancer vaccine is being created to analyse how pre-cancerous cells develop to target the disease before it takes hold.

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

Cancer has long been one of the most feared diseases in the world. Now, a groundbreaking development in vaccine technology ...

Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...

With such volatility, SLXN has emerged as one of the most talked-about stocks of the day, creating a buzz in the biotechnology sector. Let’s dive into the details behind this remarkable movement and ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, ...

Seattle doctors developed a blood test that determines the parental origin of the RB1 mutation in retinoblastoma.

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks ...

The company is in the midst of a rebranding initiative, which will soon reflect its name change to IMAC Holdings, Inc., doing business as Ignite Sciences, Inc. This transition signals its sharpened ...